Biosimilar Product Development: Regulatory Challenges & Key Insights
In this era where the demand for affordable healthcare is increasing every day, biosimilars that are replacements for biologics have […]
Bioconjugates: Combining the Best of Biologics and Small Molecules
Bioconjugates are molecules formed by chemically linking two or more molecules, typically involving a biological molecule like a protein, enzyme,
Global Regulation of Infant Formulas
Infant formula plays a crucial role in providing essential nutrition to infants who cannot be breastfed, helping to support their
Biosimilars vs. Generics: Key Differences and Market Implications
In pharmaceuticals, biosimilars and generics are two important categories that often come up in discussions about drug affordability and accessibility.
Regulatory Intelligence In Product Registration
Today ‘s age of AI has brought in tremendous success almost in every stream. Remarkably, AI has achieved tremendous success
Biologics and Biosimilars Regulations and Registration in South Korea
The Korean pharmaceutical market is estimated to be worth $24.3 billion in 2019, and between 2015 and 2019, it grew
COFEPRIS Product Classification Consultation for Food Supplements in Mexico
Navigating the regulatory landscape when introducing food supplements into the Mexican market requires careful consideration of various factors. One critical
Top 11 Regulatory Information Management Software
Demand for regulatory information management software is growing due to increasing compliance requirements from health authorities, such as XEVMPD, IDMP,
Updated List of Approved Fixed-Dose Combinations (FDC) from CDSCO, India
The CDSCO serves as the main authority regulating pharmaceuticals in India. To help comply with the safety, quality, and manufacturing